Myron Holubiak
2016
In 2016, Myron Holubiak earned a total compensation of $432.8K as Chief Executive Officer at Citius Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $112,500 |
|---|---|
| Option Awards | $95,346 |
| Salary | $225,000 |
| Total | $432,846 |
Holubiak received $225K in salary, accounting for 52% of the total pay in 2016.
Holubiak also received $112.5K in non-equity incentive plan and $95.3K in option awards.
Rankings
In 2016, Myron Holubiak's compensation ranked 11,669th out of 14,075 executives tracked by ExecPay. In other words, Holubiak earned more than 17.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,669 out of 14,075 | 17th |
Division Manufacturing | 4,553 out of 5,486 | 17th |
Major group Chemicals And Allied Products | 1,627 out of 1,900 | 14th |
Industry group Drugs | 1,317 out of 1,543 | 15th |
Industry Pharmaceutical Preparations | 1,017 out of 1,173 | 13th |
Source: SEC filing on December 13, 2017.
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2016.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018